Heart failure / cardiovascular risk
Who may qualify: US adults at risk of heart failure / cardiovascular events.
The clinical trials library
Browse studies that are actively enrolling across the U.S. Many reimburse time and travel, and compensation may be available. There's never any cost to take part.
Who may qualify: US adults at risk of heart failure / cardiovascular events.
Who may qualify: US adults 18โ70 with alcohol-induced liver damage; no recent stroke, heart attack, dialysis, or blood thinners.
Who may qualify: US adults 18โ75 with involuntary bladder leakage from a traumatic spinal cord injury 1โ12 yrs ago; excludes MS, Parkinson's, encephalitis.
Who may qualify: 18โ75, diagnosed type 1 or 2 diabetes, nerve pain in feet/hands 6+ months, on diabetes meds, no foot ulcers.
Who may qualify: 40โ80, current/former smokers (10+ pack-years) with 3+ of: high BP, diabetes, kidney disease, high cholesterol, obesity.
Who may qualify: 18โ65 with a physician diagnosis of cirrhosis, NAFLD/NASH, fibrosis, or hemochromatosis; not chronic Hep B.
Who may qualify: 18โ80 with a physician diagnosis of liver cirrhosis from MASH; no serious complications or Hep B/C / alcoholic liver disease.
Who may qualify: 50+ with a history of atherosclerosis and comorbidities; no prior major cardiovascular events.
Who may qualify: 18+ with type 2 diabetes, HbA1c 7โ11% (or unsure), managed by diet/exercise or stable oral meds for 3 months.
Who may qualify: US residents 18โ75 diagnosed with type 2 diabetes.
Who may qualify: US adults 18โ75, esp. outdoor/hiking/high-tick regions (Northeast & Midwest).
Who may qualify: 50โ64 in excellent health, no smoking history ever, no recent COVID vaccine/diagnosis, no comorbidities.
Who may qualify: Parents/guardians of a child 0โ17 with prurigo nodularis (itch 7+/10, 6+ bumps); never used Dupixent.
Who may qualify: Parents/guardians of a 1-year-old with no prior chickenpox or named immune disorders.
Who may qualify: Adolescents with no COVID vaccine/diagnosis in 3 months and no major chronic conditions.
Clinical trials sound intimidating, but the process is more structured and supportive than most people expect. Here's a plain-language walkthrough of how participation actually works, from screening to follow-up.
Sleep apnea is often treated like a switch that's either on or off. Real life is more nuanced. While lifestyle changes won't cure it, evidence shows they can meaningfully reduce symptoms and make standard treatments easier to live with.
Surgery is rarely the first option for sleep apnea. Knowing when it enters the conversation โ and why โ can make the decision feel less overwhelming and more grounded in evidence.